XBIOXenetic Biosciences, Inc.

Nasdaq xeneticbio.com


$ 4.01 $ -0.31 (-7.26 %)    

Friday, 03-May-2024 15:43:57 EDT
QQQ $ 441.50 $ 1.98 (0.45 %)
DIA $ 389.08 $ 0.41 (0.11 %)
SPY $ 518.08 $ 0.52 (0.1 %)
TLT $ 90.90 $ 0.05 (0.06 %)
GLD $ 214.11 $ -0.41 (-0.19 %)
$ 3.96
$ 3.85
$ 0.00 x 0
$ 0.00 x 0
$ 3.85 - $ 4.01
$ 2.55 - $ 5.97
10,877
na
6.1M
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-22-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-11-2021 03-31-2021 10-Q
13 03-16-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-12-2020 06-30-2020 10-Q
16 05-14-2020 03-31-2020 10-Q
17 03-26-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-13-2019 03-31-2019 10-Q
21 03-29-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-10-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-30-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-16-2015 09-30-2015 10-Q
35 08-19-2015 06-30-2015 10-Q
36 05-20-2015 03-31-2015 10-Q
37 04-15-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-20-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 correction-on-friday-xenetic-biosciences-q4-gaap-eps-077-beats-087-estimate-sales-67196k-miss-68000k-estimate

Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $...

 xenetic-biosciences-enters-into-research-agreement-with-university-of-virginia-for-advancement-of-dnase-based-oncology-platform

- Company building growing body of preclinical data to guide pathway to first in human trial for DNase-based oncology platform

 xenetic-biosciences-q3-eps-069-beats-112-estimate-sales-61117k-beat-46000k-estimate

Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $...

 hc-wainwright--co-downgrades-xenetic-biosciences-to-neutral

HC Wainwright & Co. analyst Joseph Pantginis downgrades Xenetic Biosciences (NASDAQ:XBIO) from Buy to Neutral.

 why-venus-concept-shares-are-trading-lower-by-over-15-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leis...

 xenetic-biosciences-inc-announces-1-for-10-reverse-stock-split-of-common-stock

 Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on a...

 mifepristone-abortion-pill-access-in-limbo-justice-department-may-ask-supreme-courts-intervention

U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeki...

 womens-reproductive-rights-us-court-preserves-access-to-abortion-pill-for-now-but-with-tighter-rules

A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely u...

 new-york-and-california-prepare-for-potential-mifepristone-ban-in-texas-with-stockpiling-of-alternative-abortion-medications

New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the F...

 attorney-generals-of-over-20-states-sound-alarm-over-suspension-of-abortion-med-approval-devastating-risks-ahead

In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's ...

 xenetic-biosciences-inc-announces-research-and-development-collaboration-with-the-scripps-research-institute-to-advance-dnase-platform

- Collaboration provides a significant step forward in the advancement of Xenetic's DNase-based oncology program towards Ph...

 us-judge-weighs-nationwide-ban-on-abortion-pills

U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regu...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION